This bottom-up investigation, from myosin molecules and muscle fibers to intact hearts, provides insights into short-term and low-dose HCQ therapy in a mouse model of DCM vs. NTg littermates. The gene discussed is MYH14; the disease is familial dilated cardiomyopathy.